Sarah Spencer
Investor Relations Contact chez VOR BIOPHARMA INC.
Postes actifs de Sarah Spencer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VOR BIOPHARMA INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Historique de carrière de Sarah Spencer
Anciens postes connus de Sarah Spencer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Public Communications Contact | 01/04/2019 | 01/04/2021 |
| GSK PLC | Public Communications Contact | - | - |
Formation de Sarah Spencer
| State University of New York at Buffalo | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 2 |
Opérationnelle
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
| Investor Relations Contact | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Sarah Spencer
- Expérience
